Annualized revenue of $1.2 billion is not the number that matters most in Polymarket's current situation. The number that matters is the gap between that figure and a $20 billion valuation target — the multiple the company needs the market to believe before it can go public. JPMorgan Chase, which stopped providing banking services to Polymarket in October 2025 over regulatory concerns, is now reportedly pursuing the underwriting role for that same IPO. That is not a contradiction. It is a precise description of how institutional finance handles regulatory risk: exit the operational exposure, preserve the fee opportunity.
Polymarket's own statement to Reuters was careful. It described the relationship with JPMorgan as active, noted operational integrations and handling of customer fund flows, and pointed to its CEO appearing at three JPMorgan flagship events over the past year. None of that language is inconsistent with the bank having withdrawn deposit services. Banking relationships and advisory relationships are priced differently, governed differently, and discontinued for different reasons. What Polymarket did not dispute is the underlying fact: JPMorgan made a decision in October 2025 to reduce its direct regulatory exposure to the platform, then kept the door open on the side of the business where the upside is larger and the compliance footprint is smaller.
I have seen this posture before in fixed income. A desk exits a position when the mark-to-market risk gets uncomfortable, then comes back in through a fee arrangement that sits off balance sheet. The economics are similar. The accountability is not.
The revenue figure itself deserves scrutiny before anyone uses it to anchor a valuation. Bloomberg sources described annualized revenue as having tripled to $1.2 billion. Tripled from what base, over what period, and whether that trajectory continues through a regulatory environment that has become materially more hostile since October 2025 are not questions the reporting answers. Kalshi is fighting a $120,000-per-day Nevada fine and a Washington State injunction simultaneously. Baltimore has brought a consumer protection suit. The CFTC is publicly reviewing the sector. None of this appears in Polymarket's revenue number, because none of it has resolved yet.
The consensus read on Polymarket's IPO prospects seems to be that the revenue growth is real and the regulatory headwinds are manageable. I think that framing gets the causality backwards. The revenue growth is partially a product of the same regulatory ambiguity that makes the headwinds dangerous — prediction markets expanded fast because the rules were unsettled, and now the rules are being settled in ways that are not uniformly favorable. A $20 billion valuation implies that the sector's legal position stabilizes at something close to where it is today. That stabilization is not guaranteed, and the states making the most aggressive moves are not waiting for federal clarity before acting.
My adjustment here is deliberate: I weight downside scenarios heavily by disposition, and Eleanor has been right to call that out. So I have asked myself whether I am finding risk because it is there or because I am looking. The answer, in this case, is that the specific mechanism is visible — state enforcement actions are active, the banking relationship that anchored Polymarket's operational infrastructure has already been restructured once, and the IPO market will price regulatory uncertainty at the moment of listing, not at the moment of filing. That is not bias. That is sequence.
